Clinical Trials Logo

Post-stroke Depression clinical trials

View clinical trials related to Post-stroke Depression.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT03761303 Withdrawn - Clinical trials for Post-stroke Depression

rTMS as an add-on Therapy in Patients With Post-stroke Depression

Start date: May 1, 2018
Phase: N/A
Study type: Interventional

About 50% of all stroke patients develop post-stroke depression (PSD). A meta-analysis has shown that rTMS treatment can reduce depressive symptoms in PSD patients. In addition to rTMS alone for the improvement of depression, the question arises as to whether a combination therapy of rTMS plus antidepressant medication can achieve a stronger or longer-term effect in PSD patients. Unfortunately, there are currently no trials of combination therapy with rTMS and drug therapy in PSD patients. Therefore, this study will investigate whether combination therapy of antidepressant and rTMS can provide additional relief of depressive symptoms compared to antidepressant and sham rTMS therapy. It is assumed that the additional active rTMS achieves a faster normalization of affect and drive than with a sham rTMS, so that the patients benefit from neurorehabilitation measures earlier and more sustainably.